Series F - Fractyl Health

Series F - Fractyl Health

Investment Firm

Overview

Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.

Announced Date

Aug 15, 2022

Funding Type

Series F

Highlights

Location

United States, North America

Social

Investor Lead

Taiwania Capital Management Corporation

Taiwania Capital Management Corporation

Taiwania Capital Management Corporation is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

10

Investor Name
Participant InvestorEmergent Medical Partners
Participant InvestorGoogle Ventures
Participant InvestorBessemer Venture Partners
Participant InvestorGeneral Catalyst
Participant InvestorTrue Ventures

Round Details and Background

Fractyl Health raised an undisclosed amount on 2022-08-15 in Series F

Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 15, 2022
Series F - Fractyl Health
10-undefined
Nov 19, 2015
Series C - Fractyl Health
5-57.0M
Sep 04, 2014
Series B - Fractyl Health
4-19.8M
Mar 21, 2013
Series A - Fractyl Health
-14.3M

Recent Activity

There is no recent news or activity for this profile.